KR102256804B9 - N-페닐-2-티아졸-5-카복사미드 유도체, 이의 약학적으로 허용 가능한 염 및 이를 유효성분으로 함유하는 미백 소재 조성물 - Google Patents
N-페닐-2-티아졸-5-카복사미드 유도체, 이의 약학적으로 허용 가능한 염 및 이를 유효성분으로 함유하는 미백 소재 조성물Info
- Publication number
- KR102256804B9 KR102256804B9 KR1020190022534A KR20190022534A KR102256804B9 KR 102256804 B9 KR102256804 B9 KR 102256804B9 KR 1020190022534 A KR1020190022534 A KR 1020190022534A KR 20190022534 A KR20190022534 A KR 20190022534A KR 102256804 B9 KR102256804 B9 KR 102256804B9
- Authority
- KR
- South Korea
- Prior art keywords
- ylaminothiazol
- pyrimidin
- phenyl
- pharmaceutically acceptable
- active ingredient
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- 239000000463 material Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 230000002087 whitening effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190022534A KR102256804B1 (ko) | 2019-02-26 | 2019-02-26 | N-페닐-2-(피리미딘-4-일아미노)티아졸-5-카복사미드 유도체, 이의 약학적으로 허용 가능한 염 및 이를 유효성분으로 함유하는 미백 소재 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190022534A KR102256804B1 (ko) | 2019-02-26 | 2019-02-26 | N-페닐-2-(피리미딘-4-일아미노)티아졸-5-카복사미드 유도체, 이의 약학적으로 허용 가능한 염 및 이를 유효성분으로 함유하는 미백 소재 조성물 |
Publications (3)
Publication Number | Publication Date |
---|---|
KR20200104083A KR20200104083A (ko) | 2020-09-03 |
KR102256804B1 KR102256804B1 (ko) | 2021-05-26 |
KR102256804B9 true KR102256804B9 (ko) | 2022-07-18 |
Family
ID=72450302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190022534A KR102256804B1 (ko) | 2019-02-26 | 2019-02-26 | N-페닐-2-(피리미딘-4-일아미노)티아졸-5-카복사미드 유도체, 이의 약학적으로 허용 가능한 염 및 이를 유효성분으로 함유하는 미백 소재 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102256804B1 (ko) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101809375B1 (ko) * | 2016-08-29 | 2017-12-14 | 연세대학교 산학협력단 | Src 키나제 억제제를 포함하는 백반증 개선 또는 백모 치료용 약학적 조성물 |
CN108473487B (zh) * | 2016-12-13 | 2021-08-03 | 普林斯顿药物研发公司 | 一种蛋白激酶抑制剂 |
DK3391907T3 (da) * | 2017-04-20 | 2020-03-09 | Iomx Therapeutics Ag | Intracellulær kinase sik3, der er associeret med resistens over for antitumorimmunresponser, og anvendelser deraf |
-
2019
- 2019-02-26 KR KR1020190022534A patent/KR102256804B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR102256804B1 (ko) | 2021-05-26 |
KR20200104083A (ko) | 2020-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2016064082A3 (ko) | 신규한 아미노알킬벤조티아제핀 유도체 및 이의 용도 | |
WO2018165404A8 (en) | Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol | |
EP4233846A3 (en) | Pharmaceutical formulations | |
EP3894398A4 (en) | 3,3-DIFLUORALLYLAMINES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
EP4041734A4 (en) | NOVEL DERIVATIVES WITH 1,2,3,4-TETRAHYDRONAPTHALENE UNIT OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
EP3613419A4 (en) | PHARMACEUTICAL COMPOSITION WITH INDIRUBY DERIVATIVE AS THE ACTIVE SUBSTANCE | |
EP4041733A4 (en) | NOVEL DERIVATIVES CONTAINING 2,3-DIHYDRO-1H-INDENE OR 2,3-DIHYDROBENZOFUUR, OR A PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
PH12017502376B1 (en) | Oral solid formulation containing irinotecan and method of preparing the same | |
EP3768675A4 (en) | NEW TRIAZOLONE DERIVATIVES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
IL289932A (en) | History of 6,3-diamino-pyridazin-3-yl, pharmaceutical preparations containing them and their use as pro-apoptotic agents | |
IL274715A (en) | A method for producing (3s)-3-(4-chloro-3-{[(2s,3r)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3- Cyclopropylpropanoic acid and its crystalline form for use as a pharmaceutical ingredient | |
EP3539978A4 (en) | NKX3.2 FRAGMENT AND PHARMACEUTICAL COMPOSITION WITH IT AS THE ACTIVE INGREDIENT | |
GB2590189B (en) | Lycorine derivative, and pharmaceutical composition and use thereof | |
EP4015042A4 (en) | PHARMACEUTICAL COMPOSITION WITH ANTIFUNGAL AS AN ACTIVE SUBSTANCE | |
WO2016006974A3 (en) | Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof | |
MX2019008338A (es) | Composicion farmaceutica que contiene sulglicotido o una sal farmaceuticamente aceptable del mismo para la prevencion o tratamiento del ojo seco. | |
MX2019001771A (es) | Composición farmacéutica sólida que comprende el sofosbuvir amorfo. | |
EP4015002A4 (en) | ORAL PHARMACEUTICAL COMPOSITION CONTAINING A HETEROCYCLIC COMPOUND | |
EP3915986A4 (en) | HETEROARYL DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THEM AS ACTIVE PRINCIPLE | |
KR102256804B9 (ko) | N-페닐-2-티아졸-5-카복사미드 유도체, 이의 약학적으로 허용 가능한 염 및 이를 유효성분으로 함유하는 미백 소재 조성물 | |
PL3773459T3 (pl) | Sposób wytwarzania formulacji wyjściowej dla dermatologicznego preparatu przeciwsłonecznego i sposób wytwarzania dermatologicznego preparatu przeciwsłonecznego | |
ZA202201888B (en) | Imidazopyridine derivative and pharmaceutical composition comprising same as active ingredient | |
EP3404020A4 (en) | PYRIDINOL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT | |
EP3626703A4 (en) | NEW COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING THIS AS AN ACTIVE SUBSTANCE | |
WO2017064652A3 (en) | Low dose oral dipyridamole compositions and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
G170 | Re-publication after modification of scope of protection [patent] |